Grant: CIHR Fellowship
McGill University
$135,000.00
Identifying rare genetic variants causing autism spectrum disorder via whole-genome sequencing
EF 2013-14
Résumé
Currently, about 400,000 Canadians are living with autism spectrum disorder (ASD). The cost of providing lifetime care for each ASD patient is estimated to be $1.5 - 3.5 million. ASD is among the most heritable of all neuropsychiatric disorders, but its genetic risk factors are largely unknown. Because of that, the diagnosis of ASD is completely based on behavioral symptoms rather than etiology, which causes the delay of ASD diagnosis to be around the age of 3 in most children. Recent genetic studies of ASD have been focused on de novo mutations using whole-exome sequencing methods. However, de novo mutations do not provide any explanations for heritability, and thus can explain only a small percentage of all the ASD cases. We recently sequenced the whole genomes of 120 deep phenotyped ASD patients, and we plan to systematically investigate rare genetic risk variants of ASD, including copy number variants, small insertions and deletions, and single nucleotide variants, in these 120 ASD genomes. By comparing the genomes of 120 healthy internal controls and publicly available data from 1000 Genome Project (1092 health subjects), we aim to find novel rare variants with high penetrance to ASD risk. After that, we will focus on studying the functions of the genes harboring strong ASD candidate variants in cell lines and animal models. As far as we know, this is the largest whole-genome sequencing study of ASD so far. This project will greatly promote the understanding of the genetic basis and developmental pathways of ASD. Novel ASD risk genes will be valuable for early diagnosis and intervention, which are essential to increase language and IQ scores of children with ASD and reduce life span costs.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
300399
Name
Xie Pingxing
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Identifying rare genetic variants causing autism spectrum disorder via whole-genome sequencing
Programtype2
Fellowship Programs
Orgnameinp2
McGill University
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Autism Spectrum Disorder; Bioinformatics And Biostatistics; Copy Number Variants; Rare Genetic Variants; Single Nucleotide Variants; Whole-Genome Sequencing
Abstract
Currently, about 400,000 Canadians are living with autism spectrum disorder (ASD). The cost of providing lifetime care for each ASD patient is estimated to be $1.5 - 3.5 million. ASD is among the most heritable of all neuropsychiatric disorders, but its genetic risk factors are largely unknown. Because of that, the diagnosis of ASD is completely based on behavioral symptoms rather than etiology, which causes the delay of ASD diagnosis to be around the age of 3 in most children. Recent genetic studies of ASD have been focused on de novo mutations using whole-exome sequencing methods. However, de novo mutations do not provide any explanations for heritability, and thus can explain only a small percentage of all the ASD cases. We recently sequenced the whole genomes of 120 deep phenotyped ASD patients, and we plan to systematically investigate rare genetic risk variants of ASD, including copy number variants, small insertions and deletions, and single nucleotide variants, in these 120 ASD genomes. By comparing the genomes of 120 healthy internal controls and publicly available data from 1000 Genome Project (1092 health subjects), we aim to find novel rare variants with high penetrance to ASD risk. After that, we will focus on studying the functions of the genes harboring strong ASD candidate variants in cell lines and animal models. As far as we know, this is the largest whole-genome sequencing study of ASD so far. This project will greatly promote the understanding of the genetic basis and developmental pathways of ASD. Novel ASD risk genes will be valuable for early diagnosis and intervention, which are essential to increase language and IQ scores of children with ASD and reduce life span costs.
Competitiondate
201311
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Xie, Pingxing
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~